X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (212) 212
Publication (44) 44
Book Chapter (6) 6
Conference Proceeding (4) 4
Book / eBook (1) 1
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ctla-4 (146) 146
ctla‐4 (145) 145
humans (128) 128
index medicus (105) 105
ctla-4 antigen (82) 82
immunology (78) 78
immunotherapy (63) 63
animals (58) 58
t cells (54) 54
female (53) 53
male (45) 45
mice (45) 45
antigens, cd (42) 42
cancer (41) 41
oncology (40) 40
cd28 (38) 38
ipilimumab (36) 36
t-lymphocytes - immunology (35) 35
expression (32) 32
middle aged (32) 32
adult (30) 30
antigens (30) 30
melanoma (30) 30
abatacept (28) 28
autoimmunity (28) 28
antigens, differentiation - genetics (27) 27
analysis (26) 26
pd‐1 (26) 26
antigens, cd - immunology (25) 25
pd-1 (25) 25
immune checkpoint (24) 24
in-vivo (24) 24
lymphocytes (24) 24
metastatic melanoma (24) 24
antibodies, monoclonal - therapeutic use (23) 23
lymphocytes t (23) 23
melanoma - drug therapy (22) 22
activation (21) 21
regulatory t cells (21) 21
t-lymphocytes, regulatory - immunology (21) 21
cytotoxicity (20) 20
aged (19) 19
care and treatment (19) 19
dendritic cells (19) 19
antigens, differentiation - immunology (18) 18
cd4-positive t-lymphocytes - immunology (18) 18
chemical and pharmacologic phenomena (18) 18
costimulation (18) 18
genetic predisposition to disease (18) 18
regulatory t-cells (18) 18
susceptibility (18) 18
ctla-4 antigen - immunology (17) 17
hemic and immune systems (17) 17
lymphocyte activation (17) 17
transplantation (17) 17
genotype (16) 16
immunoconjugates (16) 16
melanoma - immunology (16) 16
survival (16) 16
cd28 antigens - immunology (15) 15
cell biology (15) 15
neoplasms - immunology (15) 15
nivolumab (15) 15
original (15) 15
polymorphism, genetic (15) 15
tolerance (15) 15
antigens, cd - metabolism (14) 14
ctla-4 antigen - antagonists & inhibitors (14) 14
gene frequency (14) 14
genetic aspects (14) 14
immune tolerance (14) 14
mice, inbred balb c (14) 14
monoclonal antibodies (14) 14
t-cells (14) 14
apoptosis (13) 13
case-control studies (13) 13
flow cytometry (13) 13
graves-disease (13) 13
inflammation (13) 13
lymphocyte activation - immunology (13) 13
lymphocyte-associated antigen-4 (13) 13
melanoma - pathology (13) 13
mice, inbred c57bl (13) 13
original articles (13) 13
pembrolizumab (13) 13
surgery (13) 13
therapy (13) 13
tumors (13) 13
adolescent (12) 12
alleles (12) 12
antigens, cd - genetics (12) 12
ctla-4 protein (12) 12
hematology (12) 12
immune system (12) 12
medical research (12) 12
antibodies, monoclonal - administration & dosage (11) 11
article (11) 11
cells, cultured (11) 11
ctla-4 antigen - genetics (11) 11
disease (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Book
International Journal of Cancer, ISSN 0020-7136, 2015, Volume 136, Issue 1, pp. 127 - 137
Cancer immunotherapy induces a variety of autoinflammatory responses, including those against the thyroid gland, which can be exploited to predict clinical... 
CTLA‐4 | thyroglobulin antibodies | immunotherapy | GVAX | CTLA-4 | COLONY-STIMULATING FACTOR | SECRETING TUMOR VACCINE | PHASE-II | PANCREATIC ADENOCARCINOMA | METASTATIC MELANOMA | AUTOIMMUNE THYROID-DISEASE | ONCOLOGY | GM-CSF | IMMUNE ACTIVATION | RESISTANT PROSTATE-CANCER | IPILIMUMAB | Thyroglobulin - metabolism | Autoantibodies - blood | Humans | Ipilimumab | Vaccination | Male | Antineoplastic Agents - administration & dosage | RNA, Messenger - metabolism | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | CD4-Positive T-Lymphocytes - immunology | Thyroglobulin - immunology | Colonic Neoplasms - immunology | CD8-Positive T-Lymphocytes - metabolism | Prostatic Neoplasms - blood | Pancreatic Neoplasms - mortality | Thyrotropin - blood | Colonic Neoplasms - therapy | Pancreatic Neoplasms - blood | Colonic Neoplasms - mortality | Antibodies, Neoplasm - blood | Cancer Vaccines - administration & dosage | RNA, Messenger - genetics | CD4-Positive T-Lymphocytes - metabolism | Combined Modality Therapy | Prostatic Neoplasms - mortality | Cancer Vaccines - immunology | Antibodies, Monoclonal - administration & dosage | Pancreatic Neoplasms - immunology | Survival Analysis | Thyroglobulin - genetics | Cell Line, Tumor | Colonic Neoplasms - blood | CD8-Positive T-Lymphocytes - immunology | Cohort Studies | Pancreatic Neoplasms - therapy | Medical research | Immunoglobulins | Pancreatic cancer | Immunotherapy | Colorectal cancer | Vaccines | Prostate cancer | Thyroglobulin antibodies
Journal Article
Cancer, ISSN 0008-543X, 10/2019, Volume 125, Issue 19, pp. 3312 - 3319
The position of immunotherapy as a pillar of systemic cancer treatment has been firmly established over the past decade. Immune checkpoint inhibitors are a... 
CTLA‐4 | pembrolizumab | durvalumab | nivolumab | tremelimumab | PD‐1 | hepatocellular carcinoma | checkpoint inhibitor | CTLA-4 BLOCKADE | DENDRITIC CELLS | DOXORUBICIN | DEATH | SORAFENIB | CANCER | HEPATITIS | ONCOLOGY | CTLA-4 | AGENTS | PD-1 | EPIDEMIOLOGY | MONOCYTE DIFFERENTIATION | Tyrosine | Liver cancer | Inhibitors | Immune checkpoint | Immunotherapy | Medical treatment | Hepatocellular carcinoma | Kinases | Protein-tyrosine kinase | Immune system | Cancer
Journal Article
Journal of the Peripheral Nervous System, ISSN 1085-9489, 10/2019, Volume 24, Issue S2, pp. S74 - S85
Immune checkpoint inhibitors (ICIs) are increasingly used and are becoming the standard of care in the treatment of various tumor types. Despite the favorable... 
CTLA‐4 | pembrolizumab | immune checkpoint inhibitor | nivolumab | myositis | myasthenia gravis | demyelinating polyradiculoneuropathy | PD‐1 | peripheral neuropathy | PD‐L1 | Myasthenia gravis | Corticoids | Immune checkpoint | Intravenous administration | Demyelination | Toxicity | Immunotherapy | Myositis | Neuromuscular junctions | Myasthenia | Neuromuscular system | Movement disorders
Journal Article
Immunological Reviews, ISSN 0105-2896, 05/2009, Volume 229, Issue 1, pp. 12 - 26
T‐cell activation is mediated by antigen‐specific signals from the TCRζ/CD3 and CD4–CD8–p56lck complexes in combination with additional co‐signals provided by... 
CD28 | CTLA‐4 | apoptosis | PKB/AKT | TRIM | CTLA-4 | Apoptosis | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | FUNCTION IN-VIVO | PKB | KINASE-C-THETA | IL-2 PROMOTER ACTIVATION | PHOSPHATIDYLINOSITOL 3-KINASE | AKT | IMMUNOLOGY | ALDRICH-SYNDROME PROTEIN | T-CELL-RECEPTOR | CLATHRIN-ASSOCIATED PROTEIN | IMMUNOLOGICAL SYNAPSE | NF-KAPPA-B | Inducible T-Cell Co-Stimulator Protein | Antigens, CD - immunology | Humans | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - immunology | Antigens, CD - metabolism | CD28 Antigens - metabolism | Signal Transduction - immunology | Lymphocyte Activation - immunology | T-Lymphocytes - metabolism | Adaptor Proteins, Signal Transducing - immunology | Microfilament Proteins - metabolism | Contractile Proteins - metabolism | 3-Phosphoinositide-Dependent Protein Kinases | Protein-Serine-Threonine Kinases - metabolism | Antigens, Differentiation, T-Lymphocyte - immunology | Antigens, Differentiation, T-Lymphocyte - metabolism | CD28 Antigens - immunology | Filamins | CTLA-4 Antigen | Animals | Microfilament Proteins - immunology | Contractile Proteins - immunology | Protein-Serine-Threonine Kinases - immunology | T-Lymphocytes - immunology | Adaptor Proteins, Signal Transducing - metabolism | Autoimmunity | Phosphatidylinositol | Phosphatases | T cells | Protein kinases
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 06/2019, Volume 234, Issue 6, pp. 8509 - 8521
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2019, Volume 145, Issue 8, pp. 2238 - 2248
Journal Article